Jie Xiong

7PUBLICATIONS
21CO-AUTHORS
Cellular nervous systemHaematological tumoursSolid tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2026
Single-cell profiling of natural killer/T-cell lymphoma reveals stratified immune features and potential therapeutic implications.

|Aug 24, 2026
Multimodal spatial profiling reveals distinct myeloid-defined ENKTL subgroups and tumor-myeloid cooperativity within prognostic inflammatory niche.

|Jun 29, 2026
LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling.

|May 21, 2026
The N6-methyladenosine reader IGF2BP2 in T-cell lymphoma.

|Jun 10, 2025
Baseline total lesion glycolysis identifies high-risk patients with immunosuppressive signatures in early-stage natural killer/T-cell lymphoma.

Xiao Gao, Jie Xiong, Xin-Yun Huang

|Mar 06, 2024
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma.

Jie Xiong, Shu Cheng, Xiao Gao

Pageof 2

Frequent Collaborators

5 joint publications

Weili Zhao

1 joint publications

Yu-Ting Dai

1 joint publications

Hong-Mei Yi

1 joint publications

Yunqi Li